153 related articles for article (PubMed ID: 19141387)
1. The transcription factor LMO2 is a robust marker of vascular endothelium and vascular neoplasms and selected other entities.
Gratzinger D; Zhao S; West R; Rouse RV; Vogel H; Gil EC; Levy R; Lossos IS; Natkunam Y
Am J Clin Pathol; 2009 Feb; 131(2):264-78. PubMed ID: 19141387
[TBL] [Abstract][Full Text] [Related]
2. LMO2 is a novel predictive marker for a better prognosis in pancreatic cancer.
Nakata K; Ohuchida K; Nagai E; Hayashi A; Miyasaka Y; Kayashima T; Yu J; Aishima S; Oda Y; Mizumoto K; Tanaka M; Tsuneyoshi M
Neoplasia; 2009 Jul; 11(7):712-9. PubMed ID: 19568416
[TBL] [Abstract][Full Text] [Related]
3. The oncogenic LIM-only transcription factor Lmo2 regulates angiogenesis but not vasculogenesis in mice.
Yamada Y; Pannell R; Forster A; Rabbitts TH
Proc Natl Acad Sci U S A; 2000 Jan; 97(1):320-4. PubMed ID: 10618416
[TBL] [Abstract][Full Text] [Related]
4. The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas.
Natkunam Y; Zhao S; Mason DY; Chen J; Taidi B; Jones M; Hammer AS; Hamilton Dutoit S; Lossos IS; Levy R
Blood; 2007 Feb; 109(4):1636-42. PubMed ID: 17038524
[TBL] [Abstract][Full Text] [Related]
5. Expression of the leukemia oncogene Lmo2 is controlled by an array of tissue-specific elements dispersed over 100 kb and bound by Tal1/Lmo2, Ets, and Gata factors.
Landry JR; Bonadies N; Kinston S; Knezevic K; Wilson NK; Oram SH; Janes M; Piltz S; Hammett M; Carter J; Hamilton T; Donaldson IJ; Lacaud G; Frampton J; Follows G; Kouskoff V; Göttgens B
Blood; 2009 Jun; 113(23):5783-92. PubMed ID: 19171877
[TBL] [Abstract][Full Text] [Related]
6. Expression of Fli-1, a nuclear transcription factor, distinguishes vascular neoplasms from potential mimics.
Folpe AL; Chand EM; Goldblum JR; Weiss SW
Am J Surg Pathol; 2001 Aug; 25(8):1061-6. PubMed ID: 11474291
[TBL] [Abstract][Full Text] [Related]
7. Structure of the leukemia oncogene LMO2: implications for the assembly of a hematopoietic transcription factor complex.
El Omari K; Hoosdally SJ; Tuladhar K; Karia D; Vyas P; Patient R; Porcher C; Mancini EJ
Blood; 2011 Feb; 117(7):2146-56. PubMed ID: 21076045
[TBL] [Abstract][Full Text] [Related]
8. The expression of LMO2 protein in acute B-cell and myeloid leukemia.
Cobanoglu U; Sonmez M; Ozbas HM; Erkut N; Can G
Hematology; 2010 Jun; 15(3):132-4. PubMed ID: 20557670
[TBL] [Abstract][Full Text] [Related]
9. Identification of LMO2 as a new marker for acinic cell carcinoma of salivary gland.
Sheng D; Zhang Y; Xue T; Zhou XY; Li XQ
Diagn Pathol; 2022 Jan; 17(1):15. PubMed ID: 35094691
[TBL] [Abstract][Full Text] [Related]
10. The LIM domain protein Lmo2 binds to AF6, a translocation partner of the MLL oncogene.
Bégay-Müller V; Ansieau S; Leutz A
FEBS Lett; 2002 Jun; 521(1-3):36-8. PubMed ID: 12067721
[TBL] [Abstract][Full Text] [Related]
11. LIM-only protein Lmo2 forms a protein complex with erythroid transcription factor GATA-1.
Osada H; Grutz GG; Axelson H; Forster A; Rabbitts TH
Leukemia; 1997 Apr; 11 Suppl 3():307-12. PubMed ID: 9209374
[TBL] [Abstract][Full Text] [Related]
12. Human Bex2 interacts with LMO2 and regulates the transcriptional activity of a novel DNA-binding complex.
Han C; Liu H; Liu J; Yin K; Xie Y; Shen X; Wang Y; Yuan J; Qiang B; Liu YJ; Peng X
Nucleic Acids Res; 2005; 33(20):6555-65. PubMed ID: 16314316
[TBL] [Abstract][Full Text] [Related]
13. miR-223 and miR-142 attenuate hematopoietic cell proliferation, and miR-223 positively regulates miR-142 through LMO2 isoforms and CEBP-β.
Sun W; Shen W; Yang S; Hu F; Li H; Zhu TH
Cell Res; 2010 Oct; 20(10):1158-69. PubMed ID: 20856265
[TBL] [Abstract][Full Text] [Related]
14. Homo-binding character of LMO2 isoforms and their both synergic and antagonistic functions in regulating hematopoietic-related target genes.
Sun W; Shen WW; Yang S; Hu F; Gao Y; Qiao YH; Zhu TH
J Biomed Sci; 2010 Mar; 17(1):22. PubMed ID: 20346173
[TBL] [Abstract][Full Text] [Related]
15. The T cell leukemia LIM protein Lmo2 is necessary for adult mouse hematopoiesis.
Yamada Y; Warren AJ; Dobson C; Forster A; Pannell R; Rabbitts TH
Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3890-5. PubMed ID: 9520463
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic Utility of the Germinal Center-associated Markers GCET1, HGAL, and LMO2 in Hematolymphoid Neoplasms.
Menter T; Gasser A; Juskevicius D; Dirnhofer S; Tzankov A
Appl Immunohistochem Mol Morphol; 2015 Aug; 23(7):491-8. PubMed ID: 25203428
[TBL] [Abstract][Full Text] [Related]
17. Protein stability and transcription factor complex assembly determined by the SCL-LMO2 interaction.
Lécuyer E; Larivière S; Sincennes MC; Haman A; Lahlil R; Todorova M; Tremblay M; Wilkes BC; Hoang T
J Biol Chem; 2007 Nov; 282(46):33649-33658. PubMed ID: 17878155
[TBL] [Abstract][Full Text] [Related]
18. c-myb supports erythropoiesis through the transactivation of KLF1 and LMO2 expression.
Bianchi E; Zini R; Salati S; Tenedini E; Norfo R; Tagliafico E; Manfredini R; Ferrari S
Blood; 2010 Nov; 116(22):e99-110. PubMed ID: 20686118
[TBL] [Abstract][Full Text] [Related]
19. Targeting LMO2 with a peptide aptamer establishes a necessary function in overt T-cell neoplasia.
Appert A; Nam CH; Lobato N; Priego E; Miguel RN; Blundell T; Drynan L; Sewell H; Tanaka T; Rabbitts T
Cancer Res; 2009 Jun; 69(11):4784-90. PubMed ID: 19487290
[TBL] [Abstract][Full Text] [Related]
20. LMO2-negative Expression Predicts the Presence of MYC Translocations in Aggressive B-Cell Lymphomas.
Colomo L; Vazquez I; Papaleo N; Espinet B; Ferrer A; Franco C; Comerma L; Hernandez S; Calvo X; Salar A; Climent F; Mate JL; Forcada P; Mozos A; Nonell L; Martinez A; Carrio A; Costa D; Dlouhy I; Salaverria I; Martin-Subero JI; Lopez-Guillermo A; Valera A; Campo E;
Am J Surg Pathol; 2017 Jul; 41(7):877-886. PubMed ID: 28288039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
